Abiopharma

🔍 Freeman Kevin Lee (Executive)

Company: Health Catalyst, Inc. (HCAT)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Sold 4,578 shares of Common Stock at $3.3627 per share (Direct)
  Date: 2025-09-02 | Code: F | equity_swap_involved: false | shares_owned_after: 375,087.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.